This week, Dr. Deepak L. Bhatt will share his expertise at #ESCCongress. Join him for his sessions, including the late-breaking science presentation on "Cardiorenal Effects and Safety of Initiation of Empagliflozin After Acute Myocardial Infarction." #CardioX Icahn School of Medicine at Mount Sinai European Society of Cardiology

This weekend, DoctorKini will be presenting her work in cardiovascular health at #ESCCongress. Don't miss the opportunity to join her enlightening and informative sessions! #CardioX Icahn School of Medicine at Mount Sinai European Society of Cardiology

Join Dr. Gregg W. Stone MD on Saturday, August 31, at #ESCCongress for insightful discussions. #CardioX #CardioTwitter Icahn School of Medicine at Mount Sinai European Society of Cardiology

This weekend, Dr. George Dangas, MD, MACC, MSCAI will speak at #ESCCongress. Join his sessions for insightful discussions. #CardioX #CardioTwitter Icahn School of Medicine at Mount Sinai European Society of Cardiology

Mark your calendar for presentations by Dr Roxana Mehran at #ESCCongress. Gain valuable insights from her groundbreaking work. #CardioX #CardioTwitter Icahn School of Medicine at Mount Sinai European Society of Cardiology

Make sure not to miss out on the enlightening sessions by Birgit Vogel at #ESCCongress, where she will delve into her groundbreaking work. #CardioX #CardioTwitter Icahn School of Medicine at Mount Sinai European Society of Cardiology

Attend Dr.Leslee Shaw's sessions at #ESCCongress, including the late-breaking science, "Global Pretest Probability Study of Coronary Artery Disease - GPS-CAD: A Global Study of Race/Ethnicity and Geography in Coronary Artery Disease." #CardioX Icahn School of Medicine at Mount Sinai European Society of Cardiology

The CEO ⁦European Society of Cardiology⁩ #value #leaders #RISE2024 #ESCcongress Resolving conflicts so you can lead and achieve goals ⁦Women As One⁩ Values are nice, living values are better. Make it real!!

Don't miss out on sessions presented by Dr. Benjamin Bay at #ESCCongress to learn more about his latest research. #CardioX #CardioTwitter Icahn School of Medicine at Mount Sinai European Society of Cardiology

Attend Dr. Dr. Prakash Krishnan's presentation, "Open Surgery or Endovascular Approach as First-Line Treatment for Chronic Limb Ischemia: Review of Evidence From BEST-CLI and BASIL-2 and More," at #ESCCongress on Saturday, August 31. #CardioX #CardioTwitter Icahn School of Medicine at Mount Sinai European Society of Cardiology

On Saturday, August 31, Dr. Keisuke Yasumura, MD will present "Comparison of Different Calcium Modification Strategies for Coronary Calcified Nodules: Insights From Optical Coherence Tomography," at #ESCCongress. Be sure to attend. #CardioX #CardioTwitter Icahn School of Medicine at Mount Sinai European Society of Cardiology

Be sure to join Dr. Angelo Oliva MD at #ESCCongress to learn more about his work. #CardioX #CardioTwitter Icahn School of Medicine at Mount Sinai European Society of Cardiology

#cardiology #cardiovascular #cardiotwitter #cardioX European Society of Cardiology #ESCCongress

The best “Great Debate” ⁦European Society of Cardiology⁩ #ESCCogress ⁦Navin Kapur⁩ @HolgerThiele

At the ⁦Elsevier⁩ booth at ⁦European Society of Cardiology⁩ with Dr Peter Libby and Dr Bob Bonow and the Braunwald’s Heart disease family of textbooks. #cardiology

Lancet commission updates - Dr Roxana Mehran educating the audience on the importance of inclusion of women broadly in studies and the research leadership and teams. #closethegap

In a new edition of ACC's Cardiology Hour, Dr. Valentin Fuster & a panel of experts break down the top trials released during #ESCCongress, such as HELIOS-B, OCEANIC-AF, EPIC-CAD, & more! 📽️: bit.ly/4e9yoBR #CardioX #CardioTwitter JACC Journals Mount Sinai Fuster Heart Hospital

In a new edition of ACC's Cardiology Hour, Dr. Valentin Fuster & a panel of experts break down the top trials released during #ESCCongress, such as HELIOS-B, OCEANIC-AF, EPIC-CAD, & more! 📽️: bit.ly/4e9yoBR #CardioX #CardioTwitter #JACC American College of Cardiology Mount Sinai Fuster Heart Hospital

Our publ in Lancet: IPD pooled analysis of all 6 RCTs in which 23,256 pts were treated with 1-yr DAPT vs. 2wks-3mos DAPT (median 78d) followed by ticagrelor monoRx. MACE favored short DAPT, and major bleeding and mortality were reduced. Similar results in CCS & ACS, even post-MI.

The SGLT2 inhibitor empagliflozin confers kidney-protective benefits and can therefore be given safely and effectively to patients when they are hospitalized for acute myocardial infarction (MI), according to a study led by Dr. Deepak L. Bhatt: mshs.co/3TbDYf6 #CardioX